Pharmaceutical

STAT+: In the case of a devastating disease, the FDA we...

An experimental drug for FOP symbolizes a future in which years of research, adv...

STAT+: After Optum Health’s lowest profit margin in a d...

Just weeks after UnitedHealth's Optum posted its lowest profit margin in a decad...

STAT+: Hospitals are dialing back on venture capital in...

Once seen as a way to innovate, many hospitals are now dialing back on venture c...

Listen: How Long Island became the ‘eugenics capital of...

In a new episode of "Color Code," STAT explores the history of a Long Island lab...

STAT+: FDA warns AstraZeneca over misleading promotiona...

The FDA scolded AstraZeneca for making misleading claims about the effectiveness...

STAT+: SEC wants to know if key supplier of research mo...

The move comes as the Department of Justice probes a Cambodian smuggling ring th...

America’s ERs struggle with timely care for stroke pati...

Black, Hispanic, and female patients, as well as those over 80 all experienced l...

YouTube cracks down on misinformation on cancer treatment

YouTube’s health division is stepping up its effort to combat medical informatio...

STAT+: Pharmalittle: Amazon Pharmacy offers insulin dis...

Amazon Pharmacy will begin automatically applying manufacturer coupons to more t...

Radiation, a mainstay of cancer treatment, begins a fad...

“There are situations now on an individual patient basis where radiation may not...

STAT+: BMS, looking to build a market for a heart drug,...

As Bristol Myers Squibb works to build Camzyos into a blockbuster drug, it has p...

Patient advocates warn FDA proposal on salt intake coul...

Patient advocates are warning that a proposal from the FDA meant to reduce consu...

Opinion: Home blood pressure machines are often wrong. ...

These popular machines may be wildly inaccurate for people with wider or longer ...

House Democrats unveil new legislation that expands the...

In July, Democratic health leaders from the US House of Representatives proposed...

Botulinum battle heats up with FDA approving Daxxify fo...

Daxxify becomes the latest botulinum toxin to make the jump from aesthetics to t...

LifeArc invests nearly $10m in Crick Institute’s Africa...

The funding will extend support to the Institute’s Crick Africa Network for five...